化工进展
化工進展
화공진전
CHEMICAL INDUSTRY AND ENGINEERING PROGRESS
2012年
10期
2295-2299
,共5页
黄维丽%李惠萍%胡子昭%王菁%刘凯
黃維麗%李惠萍%鬍子昭%王菁%劉凱
황유려%리혜평%호자소%왕정%류개
溶度参数%黏均分子量%减阻剂%溶液聚合
溶度參數%黏均分子量%減阻劑%溶液聚閤
용도삼수%점균분자량%감조제%용액취합
solubility parameter%viscosity-average molecular weight%drag reduction agent%solution polymerization
依据溶度参数理论预测溶剂和聚合物的相容性,为合成具有更高分子量的减阻聚合物提供理论指导。实验结果表明,使用脂肪烃溶剂(正己烷、正辛烷和环己烷)和芳香烃溶剂(甲苯、苯和氯苯)合成减阻剂黏均分子量的大小顺序与依据溶度参数理论预测不同溶剂合成减阻剂的分子量大小顺序吻合。脂肪烃溶剂是α-烯烃聚合的良溶剂,芳香烃溶剂是α-烯烃聚合的不良溶剂。良溶剂中环己烷是α-烯烃聚合的最佳溶剂,易合成分子量较大的减阻剂。同时,通过室内环道评价装置及XRD和1H-NMR测试手段对聚合产物的结构和性能进行了表征。
依據溶度參數理論預測溶劑和聚閤物的相容性,為閤成具有更高分子量的減阻聚閤物提供理論指導。實驗結果錶明,使用脂肪烴溶劑(正己烷、正辛烷和環己烷)和芳香烴溶劑(甲苯、苯和氯苯)閤成減阻劑黏均分子量的大小順序與依據溶度參數理論預測不同溶劑閤成減阻劑的分子量大小順序吻閤。脂肪烴溶劑是α-烯烴聚閤的良溶劑,芳香烴溶劑是α-烯烴聚閤的不良溶劑。良溶劑中環己烷是α-烯烴聚閤的最佳溶劑,易閤成分子量較大的減阻劑。同時,通過室內環道評價裝置及XRD和1H-NMR測試手段對聚閤產物的結構和性能進行瞭錶徵。
의거용도삼수이론예측용제화취합물적상용성,위합성구유경고분자량적감조취합물제공이론지도。실험결과표명,사용지방경용제(정기완、정신완화배기완)화방향경용제(갑분、분화록분)합성감조제점균분자량적대소순서여의거용도삼수이론예측불동용제합성감조제적분자량대소순서문합。지방경용제시α-희경취합적량용제,방향경용제시α-희경취합적불량용제。량용제중배기완시α-희경취합적최가용제,역합성분자량교대적감조제。동시,통과실내배도평개장치급XRD화1H-NMR측시수단대취합산물적결구화성능진행료표정。
In this paper,the compatibility between solvent and polymer is predicted according to solubility parameter theory,and a theoretical guidance is provided for the synthesis of drag reduction agent(DRA) with high molecular weight.The experiment results show the viscosity-average molecular weight size order of DRA synthesized by aliphatic hydrocarbon solvents(n-hexane、n-octane and cyclohexane) and aromatic hydrocarbon solvents(cyclohexane、benzene and chlorobenzene) are in accordance with the molecular weight size order of DRA which was synthesized by different solvents predicted according to solubility parameter theory.Aliphatic hydrocarbon solvents are good solvents for α-olefin polymerization,and aromatic hydrocarbon solvents are poor solvents for α-olefin polymerization.Cyclohexane in good solvents is the best solvent for α-olefin polymerization,and is easy to synthesize DRA with large molecular weight.At the same time,the product structure and properties are characterized by simulative loop evaluation apparatus、XRD and1H-NMR.